Vasoactive Peptides in Portal Pressure
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study is looking at the detection of vasoactive peptides in portal hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 14, 2005
CompletedJuly 26, 2007
September 1, 2005
September 13, 2005
July 25, 2007
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- HVPG \>= 12 mmHg
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayside Healthlead
Study Sites (1)
Alfred Hospital
Melbourne, Victoria, 3181, Australia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William W Kemp, MBBS, FRACP
The Alfred
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 14, 2005
Last Updated
July 26, 2007
Record last verified: 2005-09